<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">a-novel-five-gene-signature-predicts-overall-and-r</item><item key="factor_count">2</item><item key="sample_count">8</item><item key="tags"><item>cancer</item><item>cell</item><item>genome</item><item>lung</item><item>lung cancer</item><item>nsclc</item><item>stem cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-36821</item><item key="id">4450</item><item key="name">A novel five-gene signature predicts overall and recurrence-free survival in NSCLC</item></item><item><item key="slug">cd99-is-a-novel-prognostic-stromal-marker-in-non-s</item><item key="factor_count">3</item><item key="sample_count">10</item><item key="tags"><item>atlas</item><item>cancer</item><item>cell</item><item>lung</item><item>lung cancer</item><item>membrane</item><item>nsclc</item><item>protein</item><item>stroma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33363</item><item key="id">4290</item><item key="name">CD99 is a novel prognostic stromal marker in non-small cell lung cancer</item></item><item><item key="slug">comparative-gene-expression-analysis-of-mesenchyma</item><item key="factor_count">2</item><item key="sample_count">10</item><item key="tags"><item>cancer</item><item>lung</item><item>nsclc</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-23066</item><item key="id">2547</item><item key="name">Comparative gene expression analysis of mesenchymal stem cells (MSC) derived  from non-small cell lung cancer (NSCLC) and corresponding normal lung tissue (NLT)</item></item><item><item key="slug">expression-data-regulated-by-hmof-in-non-small-cel</item><item key="factor_count">2</item><item key="sample_count">4</item><item key="tags"><item>cell</item><item>nsclc</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-40424</item><item key="id">4563</item><item key="name">Expression data regulated by hMOF in non-small cell lung cancer (NSCLC) cell lines</item></item><item><item key="slug">expression-data-from-egfr-wt-or-egfr-mutant-nsclc</item><item key="factor_count">3</item><item key="sample_count">32</item><item key="tags"><item>cell</item><item>lung</item><item>nsclc</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-57156</item><item key="id">2023</item><item key="name">Expression data from EGFR WT or EGFR mutant NSCLC with or without erlotinib</item></item><item><item key="slug">downstream-targets-of-id1-transcription-factor-in</item><item key="factor_count">3</item><item key="sample_count">10</item><item key="tags"><item>bladder cancer</item><item>breast</item><item>cancer</item><item>cell</item><item>helix</item><item>lung</item><item>lung cancer</item><item>nsclc</item><item>prostate</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-38944</item><item key="id">2468</item><item key="name">Downstream targets of ID1 transcription factor in Non-Small Cell Lung Carcinoma (NSCLC)</item></item><item><item key="slug">dusp1mkp1-promotes-angiogenesis-invasion-and-metas</item><item key="factor_count">0</item><item key="sample_count">2</item><item key="tags"><item>cancer</item><item>cell</item><item>line</item><item>lung</item><item>lung cancer</item><item>nsclc</item><item>serum</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19592</item><item key="id">3528</item><item key="name">DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small cell lung cancer</item></item><item><item key="slug">methylation-profiling-of-human-nsclc-promoter-regi</item><item key="factor_count">0</item><item key="sample_count">7</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>colon</item><item>colon cancer</item><item>lung</item><item>lung cancer</item><item>nsclc</item><item>peripheral</item><item>prostate</item><item>prostate cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-6695</item><item key="id">4854</item><item key="name">Methylation profiling of human NSCLC promoter regions identifies novel methylation markers for multiple malignancies</item></item><item><item key="slug">nicotinic-acetylcholine-receptors-and-egf-induce-c</item><item key="factor_count">2</item><item key="sample_count">4</item><item key="tags"><item>adenocarcinoma</item><item>cancer</item><item>cell</item><item>central</item><item>cytokine</item><item>line</item><item>lung</item><item>lung adenocarcinoma</item><item>lung cancer</item><item>nsclc</item><item>protein</item><item>stem cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-44617</item><item key="id">2229</item><item key="name">Nicotinic acetylcholine receptors and EGF induce c-Kit ligand/Stem Cell Factor (SCF) in a &#946;-arrestin-1 and E2F1 dependent manner in NSCLC</item></item><item><item key="slug">nsclc-cells-treated-with-gefitinib</item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>nsclc</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-23206</item><item key="id">3757</item><item key="name">NSCLC cells treated with Gefitinib</item></item></data></biogps>
